Transcript from ABC
News on Pancreatic Cancer
JACK FORD, ABC NEWS
In Virginia today, there was
the start of the highly unusual medical conference. A major
meeting on alternative cancer treatments, which is sponsored
in part by the government. Some of the countries leading cancer
specialists are discussing the latest research on Chinese
herbal remedies and homeopathic treatments. ABC’s John
McKenzie now on one of the most promising new alternative
treatments.
JOHN MCKENZIE, ABC
NEWS
(VO) Dr. Nicholas Gonzalez has a small, private practice in
New York City, but here at this conference he’s getting
a lot of attention. Gonzalez has earned a $ 1.4 million grant
from the National Institutes of Health to conduct one of the
largest clinical trials of an alternative cancer therapy.
DR. JEFFREY WHITE,
NATIONAL CANCER INSTITUTE
His results were the kind of results that make you sit up
and take notice.
JOHN MCKENZIE
(VO) And with the therapy that involves pig pancreatic enzymes
in the form of pills, 60 to 80 of them a day.
DR. NICHOLAS GONZLALEZ
Of coarse, there were skeptics and critics and people thought
it was bizarre.
John McKenzie
(VO) Bizarre perhaps, but not new. More than 90 years ago
John Beard, a Scottish scientist at the University of Edinburgh,
documented cases of cancer patients successfully treated with
pancreatic enzymes.
(OC) Normally pancreatic enzymes produced
in the body help digest food, but when taken as supplements
on an empty stomach they appear to be absorbed into the blood
stream and attack cancer cells throughout the body.
(VO) Gonzalez has now treated more than
400 patients and a variety of advanced cancers. Mort Schneider’s
body was riddled with tumors.
MORT SCHNEIDER
The surgeon told my wife that I really didn’t have much—very
long to live, possibly a few months.
John McKenzie
(VO) That was nine years ago. Today, he’s still taking
the enzyme supplements. As for the cancer, those tumors, four
in his liver and one in the pancreas, have all disappeared.
Even more impressive to the scientific community was the small,
pilot study Gonzalez published last year: Eleven patients
with advanced pancreatic cancer, the most deadly form of cancer,
where the average survival is only about six months. On the
enzyme therapy, patients lasted n average of 17 months, almost
three times longer.
Jeffery White
Those results, I think, are compelling enough that you have
to follow them up with a more advanced, larger clinical trial.
John McKenzie
(VO) Putting an alternative therapy through traditional testing
to see whether it really can become a common cancer treatment.
John McKenzie, ABC News, New York. --end
Due
to the recent problem with the madcow disease,
the FDA has inspected and cleared our Natcell products
for sale.
FDA Clearance No. 110-3122937-2
NO MADCOW HERE! |
 |
|
